Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Oct;76(10):1403–1405. doi: 10.1136/jnnp.2004.043455

Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability

L Laberge 1, C Gagnon 1, S Jean 1, J Mathieu 1
PMCID: PMC1739354  PMID: 16170085

Abstract

Objectives: To assess the reliability of the Epworth Sleepiness Scale (ESS), Daytime Sleepiness Scale (DSS), Chalder Fatigue Scale (CFS), and Krupp's Fatigue Severity Scale (KFSS) in patients with myotonic dystrophy type 1 (DM1).

Methods: In total, 27 patients with DM1 were administered the questionnaires on two occasions, with a 2 week interval. Internal consistency and test retest reliability were measured using intraclass correlation coefficients (ICCs), and Cronbach's α, Cohen's κ, and Goodman-Kruskal's γ coefficients.

Results: Internal consistency of the CFS and KFSS were adequate (α>0.70) but that of the ESS was weak (α = 0.24). Both daytime sleepiness and fatigue rating scales showed significant test retest reliability. Test retest reliability for individual items revealed inconsistencies for some ESS and CFS items.

Conclusions: Reliability of the CFS, DSS, and KFSS was high, allowing their use for individual patients with DM1, but that of the ESS was lower, rendering its current usage in DM1 questionable. Fatigue rating scales such as the KFSS, which are based on the behavioural consequences of fatigue, may constitute a more accurate and comprehensive measure of fatigue severity in the DM1 population.

Full Text

The Full Text of this article is available as a PDF (59.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carskadon M. A., Dement W. C., Mitler M. M., Roth T., Westbrook P. R., Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986 Dec;9(4):519–524. doi: 10.1093/sleep/9.4.519. [DOI] [PubMed] [Google Scholar]
  2. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., Wallace E. P. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–153. doi: 10.1016/0022-3999(93)90081-p. [DOI] [PubMed] [Google Scholar]
  3. Chervin Ronald D. Epworth sleepiness scale? Sleep Med. 2003 May;4(3):175–176. doi: 10.1016/s1389-9457(03)00030-3. [DOI] [PubMed] [Google Scholar]
  4. Coccagna G., Mantovani M., Parchi C., Mironi F., Lugaresi E. Alveolar hypoventilation and hyperosmnia in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1975 Oct;38(10):977–984. doi: 10.1136/jnnp.38.10.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Griggs R. C., Wood D. S. Criteria for establishing the validity of genetic recombination in myotonic dystrophy. Neurology. 1989 Mar;39(3):420–421. doi: 10.1212/wnl.39.3.420. [DOI] [PubMed] [Google Scholar]
  6. Hansotia P., Frens D. Hypersomnia associated with alveolar hypoventilation in myotonic dystrophy. Neurology. 1981 Oct;31(10):1336–1337. doi: 10.1212/wnl.31.10.1336. [DOI] [PubMed] [Google Scholar]
  7. Harley H. G., Brook J. D., Rundle S. A., Crow S., Reardon W., Buckler A. J., Harper P. S., Housman D. E., Shaw D. J. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992 Feb 6;355(6360):545–546. doi: 10.1038/355545a0. [DOI] [PubMed] [Google Scholar]
  8. Heyer E., Tremblay M., Desjardins B. Seventeenth-century European origins of hereditary diseases in the Saguenay population (Quebec, Canada). Hum Biol. 1997 Apr;69(2):209–225. [PubMed] [Google Scholar]
  9. Hilton-Jones D. Myotonic dystrophy--forgotten aspects of an often neglected condition. Curr Opin Neurol. 1997 Oct;10(5):399–401. doi: 10.1097/00019052-199710000-00007. [DOI] [PubMed] [Google Scholar]
  10. Johns M. W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540–545. doi: 10.1093/sleep/14.6.540. [DOI] [PubMed] [Google Scholar]
  11. Johns M. W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992 Aug;15(4):376–381. doi: 10.1093/sleep/15.4.376. [DOI] [PubMed] [Google Scholar]
  12. Johns M. W. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep. 1994 Dec;17(8):703–710. doi: 10.1093/sleep/17.8.703. [DOI] [PubMed] [Google Scholar]
  13. KILBURN K. H., EAGEN J. T., HEYMAN A. Cardiopulmonary insufficiency associated with myotonic dystrophy. Am J Med. 1959 Jun;26(6):929–935. doi: 10.1016/0002-9343(59)90214-1. [DOI] [PubMed] [Google Scholar]
  14. KOHN N. N., FAIRES J. S., RODMAN T. UNUSUAL MANIFESTATIONS DUE TO INVOLVEMENT OF INVOLUNTARY MUSCLE IN DYSTROPHIA MYOTONICA. N Engl J Med. 1964 Dec 3;271:1179–1183. doi: 10.1056/NEJM196412032712302. [DOI] [PubMed] [Google Scholar]
  15. Krupp L. B., LaRocca N. G., Muir-Nash J., Steinberg A. D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 Oct;46(10):1121–1123. doi: 10.1001/archneur.1989.00520460115022. [DOI] [PubMed] [Google Scholar]
  16. Laberge Luc, Bégin Paul, Montplaisir Jacques, Mathieu Jean. Sleep complaints in patients with myotonic dystrophy. J Sleep Res. 2004 Mar;13(1):95–100. doi: 10.1111/j.1365-2869.2004.00385.x. [DOI] [PubMed] [Google Scholar]
  17. MacDonald J. R., Hill J. D., Tarnopolsky M. A. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology. 2002 Dec 24;59(12):1876–1880. doi: 10.1212/01.wnl.0000037481.08283.51. [DOI] [PubMed] [Google Scholar]
  18. Mathieu J., Boivin H., Meunier D., Gaudreault M., Bégin P. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001 Feb 13;56(3):336–340. doi: 10.1212/wnl.56.3.336. [DOI] [PubMed] [Google Scholar]
  19. Mathieu J., De Braekeleer M., Prévost C., Boily C. Myotonic dystrophy: clinical assessment of muscular disability in an isolated population with presumed homogeneous mutation. Neurology. 1992 Jan;42(1):203–208. doi: 10.1212/wnl.42.1.203. [DOI] [PubMed] [Google Scholar]
  20. Mathieu J., De Braekeleer M., Prévost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology. 1990 May;40(5):839–842. doi: 10.1212/wnl.40.5.839. [DOI] [PubMed] [Google Scholar]
  21. Miletin Michael S., Hanly Patrick J. Measurement properties of the Epworth sleepiness scale. Sleep Med. 2003 May;4(3):195–199. doi: 10.1016/s1389-9457(03)00031-5. [DOI] [PubMed] [Google Scholar]
  22. Morriss R. K., Wearden A. J., Mullis R. Exploring the validity of the Chalder Fatigue scale in chronic fatigue syndrome. J Psychosom Res. 1998 Nov;45(5):411–417. doi: 10.1016/s0022-3999(98)00022-1. [DOI] [PubMed] [Google Scholar]
  23. PHEMISTER J. C., SMALL J. M. Hypersomnia in dystrophia myotonica. J Neurol Neurosurg Psychiatry. 1961 May;24:173–175. doi: 10.1136/jnnp.24.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Perron M., Veillette S., Mathieu J. La dystrophie myotonique: I. Caractéristiques socio-économiques et résidentielles des malades. Can J Neurol Sci. 1989 Feb;16(1):109–113. [PubMed] [Google Scholar]
  25. Portwood M. M., Wicks J. J., Lieberman J. S., Duveneck M. J. Intellectual and cognitive function in adults with myotonic muscular dystrophy. Arch Phys Med Rehabil. 1986 May;67(5):299–303. [PubMed] [Google Scholar]
  26. Portwood M. M., Wicks J. J., Lieberman J. S., Fowler W. M., Jr Psychometric evaluation in myotonic muscular dystrophy. Arch Phys Med Rehabil. 1984 Sep;65(9):533–536. [PubMed] [Google Scholar]
  27. Rammohan K. W., Rosenberg J. H., Lynn D. J., Blumenfeld A. M., Pollak C. P., Nagaraja H. N. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry. 2002 Feb;72(2):179–183. doi: 10.1136/jnnp.72.2.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rubinsztein J. S., Rubinsztein D. C., McKenna P. J., Goodburn S., Holland A. J. Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence. J Med Genet. 1997 Mar;34(3):229–233. doi: 10.1136/jmg.34.3.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sharpe Michael, Wilks David. Fatigue. BMJ. 2002 Aug 31;325(7362):480–483. doi: 10.1136/bmj.325.7362.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Talbot K., Stradling J., Crosby J., Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord. 2003 Jun;13(5):357–364. doi: 10.1016/s0960-8966(03)00030-0. [DOI] [PubMed] [Google Scholar]
  31. Taylor R. R., Jason L. A., Torres A. Fatigue rating scales: an empirical comparison. Psychol Med. 2000 Jul;30(4):849–856. doi: 10.1017/s0033291799002500. [DOI] [PubMed] [Google Scholar]
  32. Tuikka R. A., Laaksonen R. K., Somer H. V. Cognitive function in myotonic dystrophy: a follow-up study. Eur Neurol. 1993;33(6):436–441. doi: 10.1159/000116989. [DOI] [PubMed] [Google Scholar]
  33. Wessely S., Powell R. Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):940–948. doi: 10.1136/jnnp.52.8.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zifko Udo A., Rupp Monika, Schwarz Sigrid, Zipko Harald T., Maida Eva M. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol. 2002 Aug;249(8):983–987. doi: 10.1007/s00415-002-0765-6. [DOI] [PubMed] [Google Scholar]
  35. van der Werf S., Kalkman J., Bleijenberg G., van Engelen B., Schillings M., Zwarts M., Netherlands Fatigue Research Group The relation between daytime sleepiness, fatigue, and reduced motivation in patients with adult onset myotonic dystrophy. J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):138–139. doi: 10.1136/jnnp.74.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES